Bluebird Bio's Series C Round

Bluebird Bio raised a round of funding on April 20, 2011.

Bluebird Bio, formerly Genetix Pharmaceuticals, is developing gene therapies for severe genetic disorders. At the heart of bluebird bio's product creation efforts is its broadly applicable gene therap…

Articles about Bluebird Bio's Series C Round: